
    
      This was a single centre, single-dose, randomized, two way cross-over study in healthy male
      subjects.

      The study consisted of the following visits:

        1. A screening visit to select eligible subjects according to the inclusion/exclusion
           criteria detailed in the study protocol.

        2. Visit 1 in which subjects who satisfied the selection criteria were assigned to one of
           the two intervention sequences (Algaecal®/ LCCS or LCCS/Algaecal®) according to the
           randomization list;

        3. Visit 2, after at least one week of wash-out in respect to visit 1. Subjects arrived at
           the centre early in the morning The first blood sample was drawn before the ingestion of
           the calcium supplement and every hour after for the following 8 hours. Urine sample were
           collected before the ingestion of the calcium supplement and every 2 hours after for the
           following 8 hours. During each study visit the subjects were present in the site centre
           from the morning to the evening. Calcium supplement was given under fasted condition and
           during the eight hours after the product ingestion, according to the protocol, only
           water ad libitum was allowed.
    
  